Mutual Funds
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)
Equity  |   Very High  |   Equity - Sectoral Fund - Pharma & Health Care
43.56   +0.35
NAV(₹) as on 10/7/2026 		0.81%
  1D 		9.67%
  1Y 		25.62%
  3Y 		16.00%
  5Y
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)
Growth Chart of the Scheme

Scheme Details
Expense Ratio:
 Launch Date:
13 Jul 2018
Exit Load:
1% on or before 15D, Nil after 15D 		AUM:
₹ 6,624.58 Crs
Lock-in:
Nil 		Investing Style:
Large Growth
Portfolio Price To Book Value:
5.85 		Min. Investment:
SIP : ₹ 100.00
Lumpsum : ₹ 5,000.00
Scheme Benchmark:
NA
Fund Manager:
Dharmesh Kakkad

FUND OBJECTIVE

To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance that the investment objectives of the scheme will be realized.

LATEST ASSET & PORTFOLIO ALLOCATION Others Equity
as on 30/6/2026 3.95 % 96.05 %
TOP HOLDINGS

Sun Pharmaceutical Industries Ltd.
12.20 %

Dr. Reddy's Laboratories Ltd.
8.22 %

Mankind Pharma Ltd.
6.98 %

Cipla Ltd.
6.67 %

Alkem Laboratories Ltd.
5.67 %

Divi's Laboratories Ltd.
5.57 %

Cohance Lifesciences Ltd.
4.31 %

Medplus Health Services Ltd.
3.66 %

Max Healthcare Institute Ltd.
3.10 %

Syngene International Ltd.
2.89 %

See All Holding
ALLOCATION BY MARKET CAP (Equity)
ALLOCATION BY RATING (Debt & Others)

No Data

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs
75.78 %

Hospital & Healthcare Servic
8.60 %

Business Support
4.22 %

Retailing
3.66 %

Trading
1.69 %

See All Sectors
PORTFOLIO CHARACTERISTICS (Debt)

No Data

5 YEAR HISTORY

Financial Year 2021-22 2022-23 2023-24 2024-25 2025-26
NAV (31/3/2026) 19.69 18.64 30.20 36.20 36.61
Net Assets (Rs Crores) 2,50,042.11 2,59,458.85 3,77,231.70 4,91,463.98 6,29,313.68
Scheme Returns(%)(Absolute) 12.51 -5.38 61.15 18.22 2.15
B'mark Returns(%)(Absolute) NA NA NA NA NA
Category Rank 47/75 63/76 12/90 6/102 33/120
RISKOMETER
Level of Risk in the Scheme

Clients will understand that their principal will be at Very High risk.

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Fund Details Inception Date Aum(₹ Crs) 1Y 3Y 5Y Since Inception
MDB Logo
Kotak Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  16.12   +0.01  
11/12/2023 ₹ 678.41 19.89% - - 20.33%
MDB Logo
Quant Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  17.31   +0.13  
17/7/2023 ₹ 391.06 11.05% - - 20.20%
MDB Logo
HDFC Pharma and Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  20.66   +0.04  
4/10/2023 ₹ 2,611.33 21.27% - - 30.15%
MDB Logo
WOC Pharma and Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  16.18   +0.05  
6/2/2024 ₹ 741.34 19.12% - - 21.94%
MDB Logo
PGIM India Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  11.53   +0.03  
6/12/2024 ₹ 103.24 15.88% - - 9.36%
MDB Logo
Bajaj Finserv Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  11.08   +0.08  
27/12/2024 ₹ 354.03 14.32% - - 6.91%
MDB Logo
Baroda BNP Paribas Health and Wellness Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  10.50   +0.05  
27/6/2025 ₹ 553.17 5.25% - - 4.87%
MDB Logo
Bandhan Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  10.87   +0.01  
28/11/2025 ₹ 322.43 - - - 8.72%
MDB Logo
ITI Pharma & Healthcare Fund-Reg(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  17.55   +0.05  
8/11/2021 ₹ 251.87 7.09% 19.43% - 12.79%
MDB Logo
Nippon India Pharma Fund(G)
Equity - Sectoral Fund - Pharma & Health Care  |   Very High |  562.29   +1.92  
5/6/2004 ₹ 9,044.23 9.18% 20.95% 12.78% 19.99%